Cargando…

Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer

Background: Bladder cancer (BLCA) ranks 10th in incidence among malignant tumors and 6th in incidence among malignant tumors in males. With the application of immune therapy, the overall survival (OS) rate of BLCA patients has greatly improved, but the 5-year survival rate of BLCA patients is still...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Bingqi, Liang, Jiaming, Li, Ding, Song, Wenping, Zhao, Shiming, Ma, Yongkang, Song, Jinbo, Zhu, Mingkai, Yang, Tiejun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429908/ https://www.ncbi.nlm.nih.gov/pubmed/34512722 http://dx.doi.org/10.3389/fgene.2021.696912

Ejemplares similares

Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer
por: Dong, Bingqi, et al.
Publicado: (2021)

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
por: Song, Jinbo, et al.
Publicado: (2021)

Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma
por: Du, Zheng, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Prognostic Genes in the Tumor Microenvironment of Colon Adenocarcinoma
por: Pan, Shenghua, et al.
Publicado: (2022)

A laparoscopic radical inguinal lymphadenectomy approach partly preserving great saphenous vein branches can benefit for patients with penile carcinoma
por: Ma, Yongkang, et al.
Publicado: (2022)

Identification of Microenvironment-Related Prognostic Genes in Bladder Cancer Based on Gene Expression Profile
por: Luo, Yongxiang, et al.
Publicado: (2019)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

A Prognostic Model for Predicting Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Bladder Urothelial Carcinoma
por: Wang, Chengbang, et al.
Publicado: (2022)

Prognostic Significance of Lineage Diversity in Bladder Cancer Revealed by Single-Cell Sequencing
por: Yu, Lu, et al.
Publicado: (2022)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer
por: Mo, Xiaocong, et al.
Publicado: (2022)

The significance of transrectal ultrasound and urologist_dually guided pelvic floor muscle exercise in improving urinary continence after radical prostatectomy
por: Huaqi, Yin, et al.
Publicado: (2023)

Correction: The significance of transrectal ultrasound and urologist_dually guided pelvic floor muscle exercise in improving urinary continence after radical prostatectomy
por: Huaqi, Yin, et al.
Publicado: (2023)

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers
por: Cui, Mengjing, et al.
Publicado: (2022)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
por: Zhang, Hongxian, et al.
Publicado: (2021)

Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis
por: Zhang, Shun, et al.
Publicado: (2022)

A Distinct Glucose Metabolism Signature of Lung Adenocarcinoma With Prognostic Value
por: Li, Ding, et al.
Publicado: (2022)

The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer
por: Jiang, Aimin, et al.
Publicado: (2020)

PD-1 inhibitor toripalimab with gemcitabine as a neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma: A case report
por: Yin, Huaqi, et al.
Publicado: (2022)

HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer
por: Tan, Zhiyong, et al.
Publicado: (2022)

Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
por: Wang, Wen-Jie, et al.
Publicado: (2020)

A Robust Immuno-Prognostic Model of Non-Muscle-Invasive Bladder Cancer Indicates Dynamic Interaction in Tumor Immune Microenvironment Contributes to Cancer Progression
por: Sun, Xiaomeng, et al.
Publicado: (2022)

Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma
por: Huaqi, Yin, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
por: Zhou, Zheng, et al.
Publicado: (2023)

Discovering Cancer Subtypes via an Accurate Fusion Strategy on Multiple Profile Data
por: Jiang, Limin, et al.
Publicado: (2019)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
por: Yi, Ruibin, et al.
Publicado: (2020)

Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma
por: Hu, Tianhao, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases
por: Mao, Miaobin, et al.
Publicado: (2021)

Identification and validation of a TTN-associated immune prognostic model for skin cutaneous melanoma
por: Wang, Qirui, et al.
Publicado: (2023)

DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC
por: Sun, Yang, et al.
Publicado: (2022)

Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer
por: Cao, Lichao, et al.
Publicado: (2022)

The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer
por: Zhong, Jiateng, et al.
Publicado: (2022)

Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma
por: Han, Zhijun, et al.
Publicado: (2022)

Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis
por: Lin, Yuda, et al.
Publicado: (2023)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i2bkrkfbb2mu4d184h8f74eqg7